On May 9, 2024, Bristol-Myers Squibb Company announced that it held its annual general meeting of shareholders on May 7, 2024, and declared voting results. Accordingly, a shareholder proposal from John Chevedden, on executive retention of significant stock was not approved.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.75 USD | -0.05% | +3.11% | -18.63% |
Jun. 04 | Bristol-Myers Squibb Says Opdivo Plus Yervoy Therapy Improves Survival of Liver Cancer Patients | MT |
Jun. 04 | Bristol Myers: positive results in liver cancer | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.63% | 84.63B | |
+42.83% | 750B | |
+34.11% | 606B | |
-5.70% | 356B | |
+18.06% | 326B | |
+4.63% | 286B | |
+17.02% | 246B | |
+9.26% | 213B | |
-4.21% | 213B | |
+2.43% | 167B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Declaration of Voting Results by Bristol-Myers Squibb Company